Clinical trial
Non-Invasive Biomarkers in Cystic Fibrosis
NCT00413140 · Maastricht University Medical Center, Other · Completed
Key facts
| NCT number | NCT00413140 |
|---|---|
| Title | Non-Invasive Biomarkers in Cystic Fibrosis |
| Official title | Biomarkers in Exhaled Breath Indicate Presence, Control and Severity of Cystic Fibrosis |
| Lead sponsor | Maastricht University Medical Center, Other |
| Collaborators | AstraZeneca Industry Cystic Fibrosis Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Cystic Fibrosis |
| Enrollment | 100 |
| Start date | Jun 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Dec 19, 2006 |
| Last update posted | Dec 19, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: